Conditions: Transthyretin Familial Amyloid Polyneuropathy
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 10
Healthy volunteers: no

Brief summary:
Tafamidis has been developed as an oral specific stabilizer of transthyretin tetramer.

Detailed description:

Arms:
arm 1: tafamidis

Interventions: intervention 1: tafamidis
Intervention descriptions: intervention 1: tafamidis meglumine 20 mg QD

Protocol document: